Aussie Suits Against Merck's Vioxx Go On As First Case Waits Appeal
This article was originally published in PharmAsia News
Executive Summary
Australian suits against Merck and its former Vioxx (rofecoxib) arthritis drug continue to move through the courts without waiting for resolution of the first case decided a year ago